|
Neogenomics Inc
NEO's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Neogenomics Inc growth rates, revenue grew
by 11.98 % in II. Quarter 2024 from the same quarter a year ago.
Ranking at No. 982
IT Infrastructure industry recorded
deterioration of revenues by -2.82 %
Neogenomics Inc net loss decreased from $-24 millions, to $-19 millions in II. Quarter 2024,
• More on NEO's Growth
|
|
Neogenomics Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 26.81 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
38.33 |
PE TTM
|
|
Company's Price to Sales ratio is at 2.82.
IT Infrastructure industry's Price to Sales ratio is at 4.26.
• More on NEO's Valuation
|
|
|
|
|
Neogenomics Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 26.81 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
38.33 |
PE TTM
|
|
Company's Price to Sales ratio is at 2.82.
IT Infrastructure industry's Price to Sales ratio is at 4.26.
Neogenomics Inc Price to Book Ratio is at 1.93 lower than Industry Avg. of 465.28. and higher than S&P 500 Avg. of 0
• More on NEO's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com